Want to join the conversation?
$VRTX said that the FDA has rejected its supplemental New Drug Application for the use of KALYDECO (ivacaftor) in people with cystic fibrosis ages two and older with one of 23 residual function mutations in the cystic fibrosis transmembrane conductance regulator gene. $VRTX plans to meet with the FDA to determine an appropriate path forward.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.